MAB-CHMINACA
- CAS No.
- 1863065-92-2
- Chemical Name:
- MAB-CHMINACA
- Synonyms
- MAB-CHMINACA;MAB-CHMINACA (CRM);MAB-CHMINACA SOLUTION;ZWCCSIUBHCZKOY-UHFFFAOYSA-N;N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide;N-[1-(Aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide;1H-Indazole-3-carboxamide, N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-
- CBNumber:
- CB72747366
- Molecular Formula:
- C21H30N4O2
- Molecular Weight:
- 370.49
- MDL Number:
- MOL File:
- 1863065-92-2.mol
- MSDS File:
- SDS
| storage temp. | -20°C |
|---|---|
| solubility | DMF: 5 mg/ml; DMSO: 10 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml; Ethanol: 1 mg/ml |
| form | A neat solid |
| FDA UNII | 5BNC061EBB |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302+H312+H332 | |||||||||
| Precautionary statements | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P321-P330-P362+P364-P501 | |||||||||
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution | |||||||||
| DEA Controlled Substances | CSCN: 7032 CSA SCH: Schedule I NARC: No |
|||||||||
| NFPA 704 |
|
MAB-CHMINACA price More Price(12)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | S-109 | MAB-CHMINACA solution 100?μg/mL in methanol, certified reference material, ampule of 1?mL, Cerilliant? | 1863065-92-2 | 1mL | $183 | 2025-07-31 | Buy |
| Cayman Chemical | 16616 | MAB-CHMINACA ≥98% | 1863065-92-2 | 1mg | $49 | 2026-04-30 | Buy |
| Cayman Chemical | 22047 | MAB-CHMINACA (CRM) | 1863065-92-2 | 1mg | $129 | 2026-04-30 | Buy |
| Cayman Chemical | 16616 | MAB-CHMINACA ≥98% | 1863065-92-2 | 5mg | $213 | 2026-04-30 | Buy |
| Cayman Chemical | 16616 | MAB-CHMINACA ≥98% | 1863065-92-2 | 10mg | $376 | 2026-04-30 | Buy |
MAB-CHMINACA Chemical Properties, Uses, Production
Description
AB-CHMINACA is an indazole-based synthetic cannabinoid (CB) that is structurally related to AB-FUBINACA (Item Nos. ISO60211 | ISO00134 | 14039), a high affinity ligand of the CB1 receptor (Ki = 0.9 nM). MAB-CHMINACA is structurally similar to AB-CHMINACA by bearing an identical cyclohexyl group; however, the isobutyl moiety is substituted with a tert-butyl group. It is a potent agonist of the CB1 receptor with a reported Ki value of 0.289 nM. This product is intended for forensic and research applications.
Uses
N-[1-(Aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide is an impurity of MAB-CHMINACA (A105960) and 5-fluoro-ADB-PINACA, an indazole-based synthetic cannabinoid that is structurally related to AB-FUBINACA, a high affinity ligand of the central CB1 receptor. it is also used in the studies on the identification and quantitation of 5-fluoro-ADB-PINACA and MAB-CHMINACA indazole-based cannabinoids in dubious herbal products. Synthetic cannabinoids.
References
[1] CARLIER J, DIAO X, SEMPIO C, et al. Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes[J]. The AAPS Journal, 2017, 71 2 1: 0. DOI: 10.1208/s12248-016-0037-5
[2] KOUTARO HASEGAWA. Postmortem distribution of MAB-CHMINACA in body fluids and solid tissues of a human cadaver.[J]. Forensic Toxicology, 2015, 33 2: 380-387. DOI: 10.1007/s11419-015-0272-y
[3] PIOTR ADAMOWICZ Joanna G. Acute intoxication of four individuals following use of the synthetic cannabinoid MAB-CHMINACA.[J]. Clinical toxicology (Philadelphia, Pa.), 2016: 650-654. DOI: 10.1080/15563650.2016.1190016
